Currently on the FDA’s drug shortage list, Adderall is in short supply due to active pharmaceutical ingredient supply issues. Teva continues to release product as it becomes available. "Consumers should be extra cautious when buying their medicines from online sources," warned the FDA. "Rogue websites and distributors may especially target medicines in short supply for counterfeiting." The press release, which can be viewed here, includes photos of the counterfeit and authentic products for comparison. The FDA encouraged consumers who believe they have received counterfeit Adderall to contact their Office of Criminal Investigations.
The shortage of drugs used to treat ADHD may have multiple etiologies. Read more about it in Psychiatric News, here.